Categories
Market News Top 10 News

Zomato Gains 20% in Grey Market Before IPO – Top Indian Market News

Zomato grey market premium hits 20%, Info Edge slashes OFS by half

Zomato, a food delivery aggregator, has reportedly hit 20% in the grey market according to sources trading in unlisted shares. This comes in light of investor excitement after SEBI approved Zomato’s IPO plans to raise Rs 8,250 crores. Info Edge, a key shareholder, has reduced its share of Offer For Sale (OFS) in half from Rs 750 crore to Rs 375 crore. Market speculation suggests that the price band of the IPO could be anywhere between Rs 70 to Rs 72 per share. 

Read more here.

HealthifyMe acquires Under45, launches vaccination slot booking

HealthifyMe has acquired Under45, a platform developed by Chennai-based techie Berty Thomas. Under45 is a platform that sends vaccination slot alerts to users opting for the service via the Telegram texting app and covers 4.1 million subscribers across 700+ channels on Telegram. Berty Thomas, the brain behind Under45, shall join HealthifyMe as an Associate Director. HealthifyMe had earlier launched vaccinateme.in, a site that helped over 80 lakh people find vaccination slots. Suchdeep Juneja (who developed mhVaccineTracker) and Chandraaditya Putuveru (who launched the Twitter bot BloreVaccine) have also onboarded the project. 

Read more here.

GRSE bags $1.8 million order for patrol boats from Bangladesh

Kolkata-based Miniratna PSU Garden Reach Shipbuilders and Engineers (GRSE), an NSE-listed company, has received an order to manufacture patrol boats for the Bangladesh Department of Fisheries. These boats will be used for surveillance to curb illegal fishing and also be used for rescue operations. The order is worth $1.8 million (~13.42 crore).

Read more here.

NTPC to buy hydrogen buses for Delhi and Ladakh

NTPC Vidyut Vyapar Nigam Ltd (a subsidiary of NTPC) has invited bids to buy hydrogen buses for Delhi and Ladakh. The company has already placed orders for 15 hydrogen cell buses with Tata Motors last week. NTPC Renewable Energy (another subsidiary of NTPC) will provide the buses with green hydrogen.

Read more here.

Ashok Leyland to ramp up production in July.

Automaker Ashok Leyland has said in an exchange filing that it is going to increase its production capacity in the coming months as demand eases. The company had intimated the closure of plants in April and May amidst the second wave of COVID-19. “The overall market demand in July’21 is better than in June’21. Consequently, our plants will be working for more number of days in July compared to May and June, ranging from 6 to 25 days across various plant locations,” said the automaker in an exchange filing. The stocks of Ashok Leyland closed down at -2.04% on the same day. 

Read more here. 

Airline stocks up as the aviation ministry increases flight capacity.

The Ministry of Civil Aviation has increased the flight capacity allowance of passengers from 50% to 65% in an official intimation. The ministry had cut down the capacity allowance from the earlier 80% to 50% in May 2021 in wake of the second wave of COVID-19 in India. Shares of Interglobe Aviation (IndiGo), Spicejet, Global Vectra Helicorp, and TAAL Enterprises surged between 2-4% the same day.

Read more here.

Sugarcane production in Maharashtra could increase by more than 200 lakh tonnes: NFCSF Chief

Jayprakash Dandegavkar, the president of the National Federation of Cooperative Sugar Factories (NFCSF), has said that Maharashtra’s sugarcane production would increase by more than 237 lakh tonnes this year. He also stated that sugar mills might have to work overtime to crush the produce by over half a month. Last year, Maharashtra had produced close to 1,012 lakh tonnes of sugarcane.

Read more here.

Maruti Suzuki Increases Production 4x in June from the previous month.

Maruti Suzuki’s production for the month of June is 1,65,576 units. This is a four-fold increase from the 40,924 units that Maruti Suzuki produced in May 2021. The company has announced a partial shutdown of factories in the month of May. 

Read more here.

Tata Motors shares dip sharply after pressure over JLR profit warning over chip shortage

The shares of Tata Motors dipped 8% after its subsidiary JLR issued a warning over negative profit numbers for September 2021 owing to chip shortage that could impact production. There is currently a global shortage of integrated circuits (also known as semiconductor chips) that are vital in manufacturing control systems of a car. To know more about the global chip crisis, click here.

Read more here.

Godawari Power turns debt-free

Godawari Power and Ispat Limited (GPIL) has officially turned debt-free after it paid its outstanding debt of Rs 457 crore. The company owed Rs 1,369 crore in standalone long-term debt, which was to be repaid by FY 2032. Due to an improvement in financial performance, GPIL was able to fully repay its outstanding debt from internal accruals.

Read more here.

Categories
Editorial

How Remdesivir Became A Matter of Life And Death

A group of angry people picketed a chemist at a big hospital in Pune when he said that the injection Remdesivir was out of stock. 6 individuals in Chandigarh,2 in Pune, and probably hundreds of such individuals all across India were arrested by the police after they were caught selling Remdesivir in the black market. There are reports of a single vial of Remdesivir selling for 10x the MRP. So what is this magical drug? Why is there a shortage? Why is there a black market thriving around it? And What is the government doing to solve its shortage? Let’s find out.

About Remdesivir

Remdesivir is an anti-viral medication currently being used to treat the COVID-19. It is originally created and developed by Gilead Sciences. Remdesivir was developed in 2009, to treat hepatitis C and respiratory syncytial virus(RSV) but failed to treat these diseases. In 2015, it was later found effective against Ebola and Marburg Viruses. The drug has currently been given an Emergency Use Authorization(EUA) by the United States Food and Drug Administration(US FDA) as well as Central Drugs Standard Control Organization in India.

The drug is quite expensive and is currently facing a shortage in India. This has caused a vicious cycle of panic-buying, hoarding, and black marketing where people are having to pay more than ten times the MRP for the medication. After the first wave of COVID-19 subsided in India pharma companies cut down on production. After the number of reported cases started to decline in September 2020, the demand for Remdesivir slumped. Companies that were left with excess stockpiles were forced to destroy them. The volume of infections and the severity in the second wave was unprecedented and the demand for the drug went up.  The already expensive Remdesivir was now being hoarded and people had to resort to the black market to buy it. 

The Economics Behind Remdesivir

  • Remdesivir currently is manufactured by 7 major pharmaceutical companies apart from other smaller ones. The companies being Mylan, Hetero, Jubilant Life Sciences, Cipla, Dr. Reddy’s, Zydus Cadila, and Sun Pharma. Hetero is the largest manufacturer of Remdesivir by numbers. India currently has a production capacity of ~38-40 lakh vials per month.
  • According to a statement by Mansukh Manadaviya, the Minister of State for Chemical and Fertilizers,  Hetero produces 10.50 lakh vials a month, Cipla makes 6.20 lakh vials, 5 lakh vials are produced by Zydus Cadila and Mylan produces 4 lakh vials. The remaining drugmakers produce vials in the range of 1 lakh and 2.5 lakh a month. He also stated that the production will be increased to around 78 lakh vials per month soon.  

  • There was a recent ‘voluntary’ reduction in price for the drug by major pharma companies. Since the distribution of Remdesivir is a haywire affair where there is uneven distribution, black marketing, and shortage of the drug, certain state governments have restricted its sale ONLY to hospitals. This move is aimed to reduce the black market of the drug where people end up paying ten times more for the drug. The government has also banned its export and cut down all import duties on the drug.
  • In the past month, the stir around the drug has definitely benefitted the share price of pharma companies. Cadila’s share price has been up by 28% in the past 1 month, CIPLA has been up by 24%, Dr. Reddy’s Laboratories has been up by 19%.
  • There is also a shortage of another drug Tocilizumab. In India, the drug is manufactured only by Cipla in partnership with Swiss-pharma company Roche Holdings AG. Similar to the case of Remdesivir, an excess demand for the drug might positively impact Cipla’s share price and revenue. 
  • While Jubilant Pharmova has been up 16%, its share price surged 8% when it announced that it had developed an oral form of Remdesivir apart from the regular injection administered. Jubilant Pharmova’s share gained special attention a month ago when ace-investors Rakesh Jhunjhunwala and his wife Rekha Jhunjhunwala increased their stake in the company.

The Hidden Picture

So far there hasn’t been a strong clinical trial report that supports the use of Remdesivir. What remains unknown is the sudden spike in usage of this one particular drug. World Health Organisation(WHO) had approved the drug for emergency usage only in the case of patients with high symptoms. For patients with mild symptoms, other drugs were prescribed. Dexamethasone is another recommended drug that costs just about Rs 6- Rs 12 in the retail market as against the few thousands paid for Remdesivir. There are other drugs prescribed for patients with mild to moderate symptoms that are cheaper than Remdesivir. 

In November 2020, WHO advised AGAINST the use of Remdesivir for treatment of COVID-19 patients. Excess use of Remdesvir can lead to a severe immunogenic reaction called the Cytokine Storm which can be fatal. The body starts to attack its own cells and tissues instead of just the virus. Even the European Union decided not to go ahead with authorizing Remdesivir after it had stockpiled the drug. Despite the global negative outlook, Indian doctors have continued to prescribe the relatively expensive drug. There might be a false demand being created over here since patients with mild symptoms are prescribed other drugs like Fabiflu, Hydroxychloroquine, Favipiravir. Treating COVID-19 might not be an expensive case after all. 

The director of AIIMS Delhi, Dr. Randeep Guleria has said that Remdesivir isn’t a magic bullet. He also said that ”Giving treatment when it is not required, you may be doing more harm than good”.

Drug Regulators, Health ministers, and agencies have advised doctors to judiciously prescribe Remdesivir, that too only for patients with severe symptoms. While pharma companies struggle to meet demand, they are facing flack from government bodies. Major Remdesivir manufacturers have companies of political pressure, calls from local corporators MLAs, and MPs. 

Pharma companies need to assess ramping up production of these vials as they face the risk of a glut/overproduction. The second wave of the deadly coronavirus has hit with an unprecedented magnitude. Individually, states have started to impose lockdowns. One can expect an increased production of Remdesivir by respective pharma companies. It won’t be before one month that we get a clearer picture of the second wave of COVID-19. Until then, Stay Home, Stay Safe!

Categories
Market News Top 10 News Top Global News

Stocks Rally Worldwide as CoVID slows – Top 10 Global News

1. Global Stocks Rally; Silver Jumps to 2013 High

Global stocks and U.S. futures climbed as concern over volatile retail trading receded and China took steps to ease a cash crunch. Silver surpassed $30 an ounce for the first time since 2013 in a Reddit-fueled buying frenzy. GameStop, AMC extended gains in early U.S. trading. The MSCI Asia Pacific Index added 1.7%, the biggest gain in three weeks. Silver futures surged as much as 12% as speculators flocked to the metal and a weekend buying binge overwhelmed online sellers of bars and coins. 

Futures on the S&P 500 Index increased 0.9% as of 8:56 a.m. New York.

The Stoxx Europe 600 Index declined 1.9%.

The MSCI Asia Pacific Index advanced 1.6%.

The MSCI Emerging Market Index advanced 1.6%.

2. Biden’s Promised $1,400 Checks Are Dividing the White House

Even within President Joe Biden’s White House, there’s debate about how to meet his promise to issue Americans another $1,400 each in stimulus checks. At least two of the president’s top economic advisers, Heather Boushey and David Kamin, have privately expressed reservations about the size of the checks and at what level they would begin to phase out for higher-income people. The aides worry that the checks will cost so much that there won’t be enough left over in Biden’s proposed pandemic relief bill for other priorities – supplemental unemployment benefits, an expanded child tax credit, or aid to states and local governments.

3. Apple Selling Bonds After Cautious Outlook Masks Best Quarter

Apple is selling bonds just days after a blowout period for sales, still eager to take advantage of cheap borrowing costs amid a cautious earnings outlook. The company is issuing debt in six parts. The longest portion of the offering, a 40-year security, may yield between 115 and 120 basis points above Treasuries. Apple is coming off a quarter in which revenue topped $100 billion for the first time. Executives didn’t provide an official forecast in reporting earnings but warned that sales growth from AirPods and other wearables will decelerate in the current period. The tech giant said it will use the proceeds for general corporate purposes, including buying back stock and paying dividends. It may also be used in funding for working capital, capital expenditures, acquisition and repayment of debt.

4. India to Borrow Big for Nearly Half-Trillion Dollar Budget

India unveiled a spending plan worth almost a half-trillion dollars as Prime Minister Narendra Modi’s government seeks to dig Asia’s third-largest economy out of a pandemic-induced slump. Fueled by bigger-than-expected spending deficits and borrowing, as well as sales of government assets and dividends from state firms, the 35 trillion rupees ($480 billion) budget sent bonds tumbling and stocks rallying. It also aims to bolster the nation’s financial stability, by increasing the foreign investment cap in insurance to 74% from 49%, planned to set up separate firms to manage stressed debt held by banks and to buy investment-grade bonds to boost confidence in the nation’s corporate debt market.

5. HSBC Doubles Down on China With New Greater Bay Area Office

HSBC will establish an office to spearhead its strategy in China’s fast-growing Greater Bay Area, stepping up its bet on the world’s second-largest economy. Daniel Chan, currently head of business banking at HSBC in Hong Kong, was named head of the unit, which will oversee the strategy to “capture opportunities” in Guangdong, Hong Kong and Macau. The move comes as Hong Kong leader Carrie Lam last week endorsed a stronger presence for HSBC in the former British colony, where it has come under criticism for freezing the accounts of activists and supporting the financial hub’s sweeping national security law. Hong Kong’s government has embraced closer ties with China since unrest hit the city in 2019, promoting the Greater Bay Area concept that seeks to create a Silicon Valley-style regional economic zone with the nearby mainland cities of Guangzhou and Shenzhen.

6. Melvin Lost 53% in January, Hurt by GameStop, Other Bets

Melvin Capital lost about 53% in January on GameStop and more than a dozen other bets after the firm found itself on the receiving end of a short squeeze started by retail investors motivated on Reddit. Melvin now has the lowest amount of leverage since the firm was founded in late 2014. The hedge fund said last week that it had “repositioned the portfolio,” including covering its GameStop short.

7. Nintendo Smashes Expectations With Best Quarter Since 2008

Nintendo raised its annual forecasts a second time after continued momentum for the Switch console helped the company to its best quarterly earnings since 2008. The Kyoto-based games company reported operating profit of 229.7 billion yen ($2.2 billion). Nintendo now expects full-year Switch sales of 26.5 million units, having already surpassed its previous projection of 24 million. The company also boosted its forecast for operating profit by 24% on the back of a surge in sales brought on by the coronavirus outbreak and hit game Animal Crossing: New Horizons. Sales remained strong even after the holidays and Nintendo has sufficient components supply for now despite industry-wide shortages.

8. London Bankers Face Location Limbo as ECB Targets Brexit Moves

A senior banker hired to work in London last year was asked just weeks later to pack his bags and move to Europe. Some trading managers at one U.S. bank still don’t know whether they’ll be able to stay in the U.K., while a young trader starting a new job at a European lender this month is waiting to learn just where that job will be. Despite years of planning for Brexit, global banks and their employers face continuing uncertainty as a threadbare trade deal for financial services and a pandemic keep the world in flux. Meanwhile, regulators are cranking up pressure on banks to execute relocation plans that were set out before Britain left the bloc on Dec. 31. 

9. EU Wins Boost From Bayer; U.K. Gets Vaccines: Virus Update

Chancellor Angela Merkel will hold crisis talks with pharmaceutical executives, regional German leaders and European Commission officials Monday to speed up the continent’s stuttering vaccination push. In a shot of welcome news before the meeting, Bayer agreed to produce CureVac NV’s experimental coronavirus vaccine to help speed up the roll-out of a promising shot. Meanwhile, Valneva, a French vaccine developer, said the U.K. government exercised an option to order 40 million extra doses of its shot for next year. Infections continued to show a slowing trend across many regions of the globe, including the U.S., though concerns remain about new variants. Italy will ease restrictions for most of the country starting Monday.

10. JPMorgan Strategists: Reddit Army Won’t Spur Big Market Drop

The battle between retail traders and hedge funds is unlikely to cause a major setback for markets, according to JPMorgan Chase & Co. Major drawdowns have usually occurred when there’s a worse outlook for growth, as well as signs of overvaluation beyond price-earnings ratios and credit spreads, JPMorgan strategists led by John Normand wrote in a note Friday. Few markets show signs of extraordinary price momentum or excessive investor leverage, he said. “The retail versus hedge fund conflict unfolding currently should be much less severe than the roughly 10% drops that have been occurring almost annually for the past two decades,” Normand wrote. “Our bubble tracker based on extreme price momentum, valuations and investor leverage isn’t flashing red at the asset class level, even if it might at the security level.”

Categories
Market News Top 10 News

India to Start Covid-19 Vaccination Drive from Jan 16 – Top Indian Market News

India to start Covid-19 vaccination drive from January 16

The Central Government announced that the nationwide Covid-19 vaccination drive will be launched on January 16. Priority will be given to nearly three crore healthcare and frontline workers. The decision was taken after Prime Minister Narendra Modi reviewed the status of India’s Covid-19 situation and vaccine preparedness. After healthcare and frontline workers, priority will be given to those above 50 years of age and the under-50 population groups with pre-existing health conditions. Around 30 crore people will be vaccinated in the first phase.

Read more here.

Avenue Supermarts Q3 Results: Net Profit rises 16% YoY to Rs 447 crore

Avenue Supermarts Ltd (DMart) reported a 16% year-on-year (YoY) increase in consolidated net profit to Rs 447 crore for the quarter ended December (Q3). The company had posted a net profit of Rs 384.04 crore in the corresponding period of FY20. Revenue from operations rose 10.8% YoY to Rs 7,542 crore in Q3 FY21. The company stated that its overall sales and sales mix is trending closer to its usual times, except for specific customer consumption changes post Covid-19.

Read more here.

Reliance Infra completes sale of 74% stake in PKTCL to IndiGrid for Rs 900 crore

Reliance Infrastructure Ltd has completed the sale of its entire 74% equity stake in Parbati Koldam Transmission Company Ltd (PKTCL) to India Grid Trust (IndiGrid) for an enterprise value of Rs 900 crore. PKTCL was a joint venture (JV) between Anil Ambani-led Reliance Infra and Power Grid Corporation of India Ltd (PGCIL). The divestment is a part of Reliance Infrastructure’s plan to divest assets to reduce debt.

Read more here.

India’s fuel demand at 11-month high in December

India’s fuel demand rose for the fourth straight month in December, as the resumption of economic activity took consumption to an 11-month high. According to provisional data released by the Oil Ministry’s Petroleum Planning and Analysis Cell, the total demand for petroleum products in December 2020 stood at 18.59 million tonnes. India had consumed 17.86 million tonnes in November.

Read more here.

CBI books Coastal Projects Ltd in connection with Rs 4,736 crore bank fraud

The Central Bureau of Investigation (CBI) has filed a case against Hyderabad-based Coastal Projects Ltd for allegedly causing a loss of over Rs 4736 crores to a consortium of banks led by the State Bank of India. CBI conducted searches at the premises of Coastal Projects, its Chairman and Managing Director Sabbineni Surendra, and other directors. Several incriminating documents have been recovered as part of an ongoing probe, which also accuses many public servants. The loan account of the company was declared fraud in February 2020.

Read more here.

Shipping Corporation to partner with IWAI to commence coastal shipping service

Shipping Corporation of India (SCI) will collaborate with the Inland Waterways Authority of India (IWAI) to commence coastal shipping services. The service will be undertaken by its Kolkata-based wholly-owned subsidiary- Inland & Coastal Shipping. The proposed development assumes significance after another state-run entity, Container Corporation of India, had discontinued its coastal shipping operation.

Read more here.

Mamata Banerjee allows 100% occupancy in cinema halls in West Bengal

West Bengal Chief Minister Mamata Banerjee has allowed 100% occupancy in cinema halls in the state but asserted following precautionary measures in the view of Covid-19. The decision comes a few days after the single screen owners sent a letter to the chief minister. They cited lesser revenues since the reopening of cinema halls in October and no known instance of the spread of Covid-19 through theatres as the basis of their demand.

Read more here.

RBI approves re-appointment of Vishakha Mulye as ICICI Bank Executive Director

The Reserve Bank of India (RBI) has approved the re-appointment of Vishakha Mulye as an Executive Director of ICICI Bank for a three-year period. The bank stated that the re-appointment is effective from January 19. ICICI Bank further stated that Shareholders at the Annual General Meeting on August 24, 2020, had already approved the re-appointment of Mr. Mulye for a period of five years effective from Jan 19, 2021. 

Read more here.

Tech Mahindra’s market cap crosses Rs 1 lakh crore mark

Tech Mahindra Ltd’s market capitalisation went past the Rs 1 lakh crore mark, helped by a rally in its stock price on Friday. At the close of trade, the company’s market valuation was at Rs 1.02 lakh crore on the NSE. The IT company’s shares saw a rise of 5.35% to close at Rs 1,048 on the NSE on Friday. Tech Mahindra has become the fifth IT firm to enter the Rs 1 lakh crore market capitalisation club, after TCS, Infosys, HCL Technologies, and Wipro.

Read more here.

Categories
Market News Top 10 News

Govt Finalises Covid-19 Vaccine Transport Module – Top Indian Market News

Govt finalises Covid-19 vaccine transport module

The Central Government has prepared a detailed draft for air transportation of Covid-19 vaccines. Pune will be the central hub from where the vaccine distribution will take place. There are a total of 41 destinations (airports) across the country that has been finalised for the delivery of vaccines. The movement of vaccines to different parts of India is likely to begin by today or tomorrow. The development comes ahead of the Covid-19 vaccine dry run in all states across the country on January 8.

Read more here.

Tata Power secures 110 MW solar power project worth Rs 488 crore from KSEB

Tata Power Company Ltd has bagged a contract worth Rs 488 crore from the Kerala State Electricity Board (KSEB) to develop a 110 MW solar project. The energy will be supplied to KSEB under a Power Purchase Agreement (PPA), valid for 25 years from the date of scheduled commercial operation. The plant is expected to generate about 274 million units (MUs) of energy per year and annually offset approximately 274 million kg of carbon dioxide. 

Read more here.

SBI raises $600 million from overseas bond sale at coupon rate of 1.8%

State Bank of India (SBI) on Thursday raised $600 million (~Rs 4,403 crore) from selling bonds to international investors at a coupon rate of 1.80%. The issue, oversubscribed by 2.1 times, is part of the SBI’s $10 billion (~Rs 73,392 crore) medium-term note programme. The 5.5-year issue, denominated in US dollars, was priced at 140 basis points (bps) over the US treasury. The bonds issued through SBI’s London branch will be listed on Singapore Exchange and India INX.

Read more here.

L&T Hydrocarbon Engineering secures offshore contract from ONGC

L&T Hydrocarbon Engineering (LTHE) has received an order from state-owned Oil & Natural Gas Corporation (ONGC). The contract involves engineering, procurement, construction, installation, and commissioning of a new living quarter platform, ‘NQL Platform’ with 120 men capacity. The platform will be constructed at NQ Complex in ONGC’s Mumbai High Asset on the west coast of India. The value of the contract ranges between Rs 2,500-5,000 crore.

Read more here.

SEBI to allow more players to set up stock exchanges, depositories

The Securities and Exchange Board of India (SEBI), through a discussion paper, has proposed to ease ownership norms for entities that plan to start new stock exchanges in India. According to the discussion paper, any resident individual/domestic institution can set up a market infrastructure institution such as a stock exchange or a depository with 100% control, provided it is a public limited company. Earlier, individuals (resident or foreign), either directly or indirectly, could not hold more than 5% in a stock exchange or a depository.

Read more here.

NMDC resumes diamond mining in Panna after forest department approval

The Madhya Pradesh Forest Department has allowed National Mineral Development Corporation Ltd (NMDC) to resume operation of its diamond mine at Majhgawan in Panna district. The operation was suspended as the environmental clearance for the mine came to an end on December 31, 2020. The state government has now extended the lease for the next 20 years. The matter of renewal of lease is pending before the State Wildlife Board and National Wildlife Board.

Read more here.

Bharat Biotech enrolls over 25,800 volunteers for Covaxin Phase-3 trials

Bharat Biotech has enrolled 25,800 volunteers for Phase-3 clinical trials of its Covid-19 vaccine- Covaxin. The recruitment was supposed to be concluded by December 31 but was extended by a week since it was short of 4,000 volunteers at that time. The trials will be conducted at around 30 clinical sites throughout India. On January 3, Oxford-AstraZeneca’s Covishield (manufactured by SII) and Bharat Biotech’s Covaxin had received approval from India’s drug regulator DCGI for emergency use authorization.

Read more here.

ABB India launches new range of circuit breakers for electrical retail market

ABB India Ltd has launched Formula DIN-Rail, a complete range of Miniature Circuit Breakers (MCBs), Residual Current Circuit Breakers (RCCBs), and Isolators for the electrical retail market. The company stated that its new range meets international standards and is manufactured in ABB’s Smart Buildings factory in Bengaluru. The ABB Formula DIN-Rail portfolio would be available through the ABB Electrification business retail network across India. It will also be available on ABB eMart, the company’s online marketplace.

Read more here.

Mahindra Logistics launches EV-driven last-mile cargo delivery service

Mahindra Logistics Ltd (MLL) has announced the launch of its electric vehicle (EV) based last-mile cargo delivery service under the brand name ‘EDel’. The new service would initially operate across 6 major cities in India, including Bengaluru, New Delhi, Mumbai, Pune, Hyderabad, and Kolkata. MLL plans to expand EDel to a total of 14 cities in the next 12 months.

Read more here.

Lupin gets USFDA nod for generic diabetes drug

Lupin Ltd has received approval from the US Food & Drug Administration (USFDA) for its Empagliflozin and Metformin Hydrochloride extended-release (ER) tablets. The tablets are indicated for the treatment of diabetes. The product will be manufactured at Lupin’s Nagpur-based manufacturing facility. As per IQVIA MAT November 2020 data, Empagliflozin and Metformin Hydrochloride ER Tablets had estimated annual sales of $357 million (~Rs 2,618 crore) in the US.

Read more here.

Categories
Market News Top 10 News

Govt Ready to Roll Out Covid-19 Vaccine by Jan 13 – Top Indian Market News

Ready to roll out Covid-19 vaccine by January 13: Health Ministry

The Union Health Ministry on Tuesday said that it is prepared to roll out the coronavirus vaccine by January 13. “Based on the feedback of the dry-run, the government said it is ready to introduce the Covid-19 vaccine within 10 days from the date of emergency use authorisation,” said Union Health Secretary Rajesh Bhushan. On January 3rd, the Drugs Controller General of India (DCGI) had announced approval for two vaccines- Oxford-AstraZeneca’s Covishield (manufactured by Serum Institute of India) and Bharat Biotech’s Covaxin. The vaccine will be first offered to one crore healthcare workers and two crore frontline & essential workers. 

Read more here.

Work in progress to set up 16,000 km of new gas pipeline network: PM Modi

Prime Minister Narendra Modi on Tuesday said that work is in progress to set up 16,000 km of a new gas pipeline network in the country, which will be completed over the next four to six years. He stated that this would help set up 700 compressed natural gas (CNG) stations and 2.1 million people to avail piped natural gas (PNG). He further said that India plans to spend $60 billion in creating gas infrastructure till 2024, which would include pipelines, liquefied natural gas (LNG) terminals, and city gas distribution (CGD) networks. PM Modi inaugurated the 450-km Kochi-Mangaluru natural gas pipeline via video conferencing today.

Read more here.

Gravita India secures contract to supply lead products to Luminous Power

Gravita India Ltd has signed an annual agreement with Luminous Power Technologies for supplying 12,000 million tonnes (MT) of refined lead and lead alloys. The contract will be executed in the calendar year 2021, which at current lead prices would be an approximate contract value of Rs 180 crore. Yogesh Malhotra, the CEO of Gravita India, stated that this agreement will help the company to boost sales and strengthen its presence in the domestic market. 

Read more here.

Dilip Buildcon incorporates SPV for road project worth Rs 882 crore

Dilip Buildcon Ltd has incorporated a special purpose vehicle (SPV) as a wholly-owned subsidiary for a new Hybrid Annuity Model (HAM) project. The SPV will be used for four laning of Dhrol-Bhadra Patiya section of NH-151A and Bhadra Patiya-Pipaliya Section of NH151A in Gujarat, through public-private partnership on a design, build, operate and transfer basis. The HAM project is worth Rs 882 crore and will be completed in 2 years.

Read more here.

Tata Power partners with SIDBI to offer affordable financing for MSMEs in rooftop solar segment

Tata Power Ltd has announced its partnership with the Small Industries Development Bank of India (SIDBI) to offer an easy and affordable financing scheme for Micro, Small, and Medium Enterprises (MSMEs) in the rooftop solar segment. The companies have joined hands to design a solar financing solution to help MSME customers with financial aid without any collateral, at an interest of less than 10%. Tata Power stated that this scheme will empower MSMEs to adopt sustainable energy for their businesses and promote greener tomorrow.

Read more here

L&T emerges as lowest bidder for Uttarakhand Railway Project

The Heavy Civil Infrastructure business of L&T Construction has emerged as the lowest bidder for Package 4 of the new broad-gauge line between Rishikesh and Karnaprayag. The scope of the engineering and construction project includes completing tunnel work, construction shaft, and ancillary works in Uttarakhand. The order, which is worth about Rs 3,338 crore, is a contract from Rail Vikas Nigam Ltd (RVNL). 

Read more here.

HCL Tech completes acquisition of Australian IT solutions firm DWS

HCL Technologies Ltd announced that it has completed the acquisition of Australian IT solutions firm DWS. In September 2020, HCL Tech had announced that it will acquire DWS, a move that will help the Noida-based company to strengthen its position in the Australian and New Zealand market. The IT company had said that the total equity value pay-out will be AUD 158.2 million (~Rs 850.33 crore). The DWS Group provides a wide range of IT services including digital transformation, application development & support, and consulting.

Read more here

Tech Mahindra partners with College of Military Engineering to build defence solutions

The research and development (R&D) arm of Tech Mahindra Ltd, Makers Lab, has collaborated with the College of Military Engineering (CME), Pune to address challenges in the field of defence through technological innovations. CME will leverage the partnership to address critical military problem statements and be future-ready using next-generation technologies of Artificial Intelligence (AI) and Robotics. As a part of this partnership, Tech Mahindra will establish a Makers Lab at CME to utilise their diverse set of capabilities and promote R&D to provide cutting-edge technology solutions for defence forces.

Read more here.

RBI imposes Rs 2.5 crore penalty on Bajaj Finance for violation of norms

The Reserve Bank of India (RBI) on Tuesday imposed a monetary penalty of Rs 2.5 crore on Bajaj Finance Limited for violation of rules pertaining to recovery and collection methods. The lapses were linked to risk management and a specific fair practice code. RBI stated that Bajaj Finance had failed to ensure that its recovery agents did not resort to harassment or intimidation of customers as part of its debt collection efforts.

Read more here.

Salasar Techno’s subsidiary secures contract worth Rs 252 crore from Texmaco

Salasar Adorus Infra LLP, a subsidiary of Salasar Techno Engineering Ltd, has entered into a work contract with Kolkata-based Texmaco Rail and Engineering Ltd. The order consists of carrying out a portion of the design, supply, installation, testing, and commissioning of ‘Ballastless Track of Standard Guage’ in the elevated viaduct section and an underground section for the Bangalore Metro Rail Project. The company stated that the value of the contract is around Rs 252 crore.

Categories
Editorial

Is India prepared for Covid-19 Vaccination? Storage, Transportation and Mock Drills

The new year started with a glorious update. DGCA has approved restricted emergency use of Oxford-AstraZeneca and Bharat Biotech shots. Both the vaccines will soon hit the market. The first in line to receive the vaccines is our health workers who have been working tirelessly since last one year. Other people who come under the priority list are those above 50 years of age and those below it having comorbidities.

https://twitter.com/adarpoonawalla/status/1345605880381784067

The main concern in 2020 was till when we can expect a vaccine? Now, in 2021, our concern is how the developed vaccine will be distributed? When it comes to India, the concern grows even further. How can the government vaccinate a country of more 1.3 billion people? Is it necessary to vaccinate everyone? How long will it take to manufacture enough vaccines for the population? How will this fragile vaccine be distributed? This all sums up to one question: How prepared India is for the Covid-19 vaccination process? Let’s find out some of the recent developments as we step in the new phase of the war against Coronavirus. 

The cold storage & training issues

The vaccines approved needs a minimum temperature every time to be effective. This temperature may vary from 2 degrees to 8 degrees. Thus, the Indian government had to put special attention to cold storage and transportation. Last month, the government notified that 29000 cold chain points, 240 walk-in coolers, 70 walk-in freezers, 45000 ice-lined refrigerators, 41000 deep freezers and 300 solar refrigerators will be utilized in the vaccination process. Many of these units have already been transferred to the states so that the vaccination drive does not get delayed. Glass vials and syringes need to be stocked in huge numbers.

Godrej is one of the leading private companies which is looking to build products which can help the government in this vaccination process. They have already announced that it will commission 11,856 units of vaccine refrigerators and deep freezers within the next 6 months. This comes after they won a tender under the Universal Immunization Programme of the union health ministry. 

Our airports have to play a pivotal role in the speedy transportation of vaccines. India’s largest airport which is in Delhi has already geared itself with cold storage facilities since last month. It has developed cold chambers which can store at least 27 lakh vials at a given point. Also, they have the capability to transport 80 lakh vials per day. This is great news for the people of Delhi who have already seen three peaks of virus till now.

It is clear that logistics is a problem, but so is the human resource. Special training modules have been designed for every rank of personnel. Medical officers, vaccinator officers, data managers, ASHA coordinators, people in transport & storage, all are being trained to deal with this special and limited vaccine. More than 1,14,000 vaccinators have already been trained so far for the world’s largest immunisation exercise.

Mock Drill 

Any nation-wide vaccination programme imposes a huge challenge in front of the government. Any lapse during the distribution can lead to fatal consequences. A more cautious approach is required and this is what the Indian government has put their focus on. 

Recently, they have conducted mock vaccine drills in four states of the country to test the smoothness of the operations. These four states were Andhra Pradesh, Gujarat, Punjab and Assam. Now, the national government has announced a dry run of vaccination will be rolled out in each state. The mock drill took place at 286 session sites across 125 districts.

This process will help the government to take note of the glitches in the system if any. The focus is to keep a check on the functionality of Co-WIN application, cold storage & transportation, and the human resource preparation which will be required when the vaccine actually comes out. 

During these dry runs, dummy vaccines are being transported from the central storage facility to cold chain points. Volunteers were sent SMSes with a date, place and time to get vaccinated. Every person who is vaccinated will be monitored for the next 30 minutes to see if there’s any ill-reaction happening to the individual. The whole process gives a rough idea about the time required and logistics that will be involved every day.

Conclusion

The world’s largest immunisation exercise won’t be easy at all. More than 75 lakh beneficiaries have already been registered on Co-WIN software. This number will only increase from here. The CM of Uttar Pradesh, Yogi Adityanath, has already stated that he expects vaccination to start around mid-January. Does it mean that within a fortnight, we will be seeing our health workers getting vaccinated? How successfully can India achieve this challenge? Can Narendra Modi and his government live up to the strong image it has worldwide? All of these questions will be answered in the next few weeks. Here, we hope that this immunisation drive works out well and we return to the pre-covid life as soon as possible.

Studies actually suggest it would be well over 2022 June before we can vaccinate all of India. The vaccines are said to be safe by experts, and the vaccination process is starting very soon. What are your opinions on this largest vaccination process in the world? Let us know in the comment section!

Categories
Market News Top 10 News

Reliance to Buy IMG Worldwide’s Stake in Sports Management JV – Top Indian Market News

Reliance Industries to buy IMG Worldwide’s stake in sports management JV

Reliance Industries Limited (RIL) will be increasing its stake in IMG-Reliance Ltd, by buying out IMG Worldwide LLC from the sports management business. The transaction will cost RIL not more than Rs 52.08 crore. IMG-R will become a wholly-owned subsidiary of the company and will be rebranded once the deal is done.

RIL had formed an equal joint venture with the international sports marketing and management firm, IMG Worldwide LLC, in 2010. The venture aimed to develop, market, and manage sports and entertainment in India. IMG is in the business of sports, events, media, and fashion, operating in more than 30 countries.

Read more here.

Govt plans dry run for Covid-19 vaccine in 4 states next week

The central government, on Friday, said that it has planned a dry run for the administration of the Covid-19 vaccine in Andhra Pradesh, Assam, Gujarat, and Punjab next week. According to the Health Ministry, each state will plan the dry run in two districts and preferably in different session type settings. The Health Ministry stated that this exercise will enable end-to-end mobilisation and testing of the Covid-19 vaccination process.

Read more here.

AAI raises objections to Adani Enterprises branding in private airports

The Airports Authority of India (AAI) has objected to Adani Enterprises Ltd (AEL) using its brand name in three airports – Mangaluru, Lucknow, and Ahmedabad. AEL had acquired the three airports two months ago. The state-owned airport operator stated that this violated the concession agreement (CA) agreed upon by the Adani group and the AAI. The agreement mandates the airports should not be branded in a manner that identifies the company or its shareholders.

Read more here.

SBI Life acquires 9% stake in Paisalo Digital for Rs 186.20 crore

SBI Life Insurance Company Ltd announced that it has acquired a nearly 9% stake in non-banking finance company Paisalo Digital for about Rs 186.20 crore. The company has acquired a total of 38 lakh equity shares (or 8.99%) at Rs 489.99 per share, for a cash consideration as an ordinary course of business on the stock exchange on December 24. Incorporated in 1992, Paisalo Digital provides loans to individuals, SMEs & MSMEs, and Joint Liability Group (microfinance) through 129 branches across the country.

Read more here.

Aavas Financiers to raise Rs 100 crore by issuing bonds via private placement

Aavas Financiers Ltd, on Friday, said its Board of Directors has approved raising Rs 100 crore by issuing bonds on a private placement basis. The company stated that rated, listed, senior, secured, redeemable, non-convertible debentures aggregating to Rs 100 crore will be issued. Aavas is engaged in the business of providing housing loans, primarily, in the unserved and unreached markets.

Read more here.

IOC to buy 15 hydrogen-fueled buses 

As a measure to push India’s hydrogen-based mobility solutions ecosystem, Indian Oil Corporation (IOC) plans to buy 15 buses that can run on hydrogen fuel. The country’s largest oil refiner and fuel retailer is also setting up a facility at its Faridabad research and development (R&D) centre to produce hydrogen to run the buses. This project is the first-ever attempt in the country to address all the aspects of hydrogen-based mobility as the ultimate green option.

Read more here.

Oaktree and Piramal increase their bids for DHFL

US-based Oaktree Capital has raised its offer for the bankrupt Dewan Housing Finance Corporation Ltd (DHFL) by Rs 1,700 crore. Oaktree’s offer came a day after Piramal raised its bid by Rs 1,000 crore and also improved its offer for a controlling stake in DHFL’s Pramerica Life Insurance Company to Rs 1,000 crore from Rs 300 crore. Oaktree’s bid for DHFL is now at Rs 36,410 crore and that of Piramal is Rs 34,909 crore.

Read more here.

NIIT board approves Rs 237-crore buyback plan

NIIT Ltd announced that its Board of Directors has approved a Rs 237-crore buyback proposal. The corporate training firm stated that up to 98.75 lakh fully paid-up equity shares will be bought back at Rs 240 per share. The buyback, which is proposed to be made under the tender offer route, is subject to shareholders’ approval by passing a special resolution through a postal ballot.

Read more here.

L&T Construction 3D prints India’s first building with reinforcement

L&T Construction has 3D printed a G+1 (Ground plus One) building with reinforcement for the first time in India. The 3D printed building, which has a built-up area of 700 sq. feet, has been built with a special, in-house developed concrete mix using indigenously available regular construction materials. The building is located at L&T Construction’s facility in Kanchipuram.

Read more here.

USFDA informs Biocon, Mylan of deferred action on biosimilar license plea

Biocon Ltd announced that its subsidiary, Biocon Biologics, and Mylan have been informed by the US Food & Drug Administration (USFDA) of deferred action on the biologics license application (BLA) for a biosimilar to drug Avastin. The drug is used to treat various types of cancers. To complete the application, the USFDA noted that an inspection of the manufacturing facility is required as a part of the standard review process.

Read more here.

Categories
Editorial

Logistics Firms That Could Benefit from Covid-19 Vaccines

Three major pharmaceutical companies have approached the Indian drug regulator for emergency use authorisation of their respective Covid-19 vaccine candidates. This includes the vaccine developed by Pfizer-BioNtech, Serum Institutes’ Covidshield (which is developed by Oxford-AstraZeneca), and Bharat Biotech’s Covaxin. All of us are eagerly waiting for the regulator to give a final verdict. 

Even if these companies get the necessary approvals, there still exists a major hurdle- how can the Covid-19 vaccine be distributed to the entire population of India? This is where logistics companies come in. Over the past few weeks, the stocks of logistics companies have shown an impressive surge. Let us take a look at potential firms that could help India to solve its vaccine distribution issue. One factor to be understood is that both cold chain and normal logistics companies will benefit, considering that there are multiple vaccines almost ready for deployment. So let us jump in.

Snowman Logistics

By now, Snowman Logistics Ltd would be a well-known company for all of us. It is India’s leading integrated temperature-controlled logistics company. They have over 31 warehouses across 15 cities. The company has also stated plans to expand its capacity to 33 cold storage facilities in 17 cities over the next two months. Snowman was one of the first companies which stated that they could offer the required logistics services for the Pfizer vaccine in India. As we know, this particular vaccine requires an ultra-cold chain of -70 degrees. Currently, Snowman Logistics’ can provide a storage and transportation chain for up to -30 degrees.

The company entered into a very promising partnership on December 10. Snowman Logistics and SpiceJet have signed a Memorandum of Understanding (MoU) for jointly distributing Covid-19 vaccines across India. As per the deal, Snowman will handle the ground services which include activities such as transportation to/from manufacturers, packing, and storage – all in the required temperature zones. SpiceJet will provide air connectivity for temperature-controlled distribution of the COVID-19 vaccines across India, as well as internationally.

Over the last 5 weeks, the share price of Snowman Logistics has gained 96%! marketfeed had prepared a very detailed analysis of the company. You can read it here.

Blue Star

Blue Star Limited is a leading manufacturer of air conditioners and commercial refrigerators. It is not strictly a logistics company, but they offer a wide range of cold storage facilities. The company has 4 major manufacturing plants which are located in Dadra, Kala Amb (Himachal Pradesh), Wada (Maharashtra), and Ahmedabad. It is interesting to know the Blue Star has a presence in more than 18 countries in the Middle East, Africa, and South Asian regions. 

The company has stated that except for transportation facilities, it will offer a wide range of cold storage facilities for the vaccine. Blue Star is making sure that its deep freezers and ice lined refrigerators (ILRs) are ready to support the storage of Covid-19 vaccines in India. They have planned to conduct additional shifts between December 2020 and April 2021 at their manufacturing plants. This is to ensure that they are ready to meet any demands made by the vaccine developers.

Over the last month, the share price of Blue Star Ltd has jumped by more than 20%.

Mahindra Logistics

Mahindra Logistics Ltd (MLL) is one of India’s leading providers of third-party logistics solutions. The company serves more than 400 corporate customers across the world. They have 16 million sq feet of warehouse space and operate in more than 650 locations. The company is known for its supply chain management solutions.

At present, MLL does not provide cold chain logistics. However, the company stated that they have recognized the need/demand for cold chain facilities in pharmaceuticals. They are currently on their path for a huge expansion into the temperature-controlled logistics space. Mahindra Logistics has stated that they will be ready with their cold storage logistics facilities for the Covid-19 vaccine by the end of the current financial year. They have also hired experienced personnel in this particular field to help them provide the best service. 

The share price of Mahindra Logistics has increased by around 6.5% over the last one month.

Blue Dart Express

Blue Dart Express Ltd is a prominent logistics company based in Mumbai. It is owned by DHL and DHL Express (Singapore) Pte Ltd. The company has a cargo line known as Blue Dart Aviation, that operates in South Asian countries. It is also one of the leading logistical firms that are gearing up to take up the huge task of transporting Covid-19 vaccines in India. 

In October, Blue Dart announced that it will offer a complete supply chain solution for the life sciences and clinical trials sector. The company has also ensured that it will provide cold chain services to ensure seamless transport of shipments like vaccines.

Over the last few months, the company has taken a proactive role in increasing its infrastructure and improving its Temperature-Controlled Logistics platform. The company has assured that it is prepared to meet any immediate large-scale demand.

Allcargo Logistics

Allcargo Logistics Ltd is a leading logistics firm headquartered in Mumbai. The company provides services such as global multimodal transport operations, pan India container freight stations, third-party logistics, and much more. It also has world-class warehousing facilities that are also integrated with cold chain storage. Allcargo has a strong presence in more than 160 countries.

Over the last month, Allcargo Logistics’s share price has shown an increase of more than 15%.

Navkar Corporation

Navkar Corporation Ltd. is engaged in Container Freight Station (CFS) operations. They are focused on capitalizing on the available opportunities in the logistics space in Western India. The company has a dedicated cold storage facility in Maharashtra. Navkar’s CFSs have the capacity to store vaccines in temperature-controlled warehouses. So it can be a very interesting pick.

Over the last month, the share price of Navkar Corp Ltd has increased by more than 56%. This has probably not fallen under your radar and can be checked out.

Conclusion

We have only selected a handful of the prominent logistics companies that have shown their interest in catering to the vaccine distribution needs in India. There are other listed firms such as Tiger Logistics India Ltd and Arshiya Limited, whose share prices have also shown a similar surge.

Once we get a confirmation of a vaccine being approved in India, all these stocks could see a huge rally. These companies could enter into partnerships with major vaccine developers in the days to come. However, there still exist certain limitations with respect to the temperature requirements for the Covid-19 vaccines. We can see that Snowman Logistics and other firms are trying to develop the technology and increase their capacities to ensure proper distribution of the vaccine for all Indians. Pfizer has even said that they plan to use their own logistics facilities to distribute the vaccine in our country. 

Do keep a close watch on all these prominent logistics companies of India. Will they be able to deliver on their promises? Will these firms be able to actively support what is to become one of the largest vaccination drives in the world? Let us wait and watch.

Categories
Editorial

Can Snowman Logistics Benefit From Covid-19?

Coronavirus has impacted everyone’s life. It’s been 9 months already but India, along with most nations, is still struggling to contain the spread of the virus. As of 2nd December, India is very close to 1 crore positive cases. All the hopes lie on scientists worldwide to discover the vaccine. Many possible vaccines have been rolled out in the past two months which are close to getting approvals from the various authorities. To know more about these possible vaccines, click here.

Discovering and testing vaccines is one challenge, but distributing them is another. As the launch of a vaccine comes near, it’s quite natural that focus will shift to many logistics companies as well. One such logistics company is Snowman Logistics.

About Snowman

Snowman is India’s leading integrated temperature-controlled logistics company. Incorporated by Amalgam Foods Limited in 1993, it is India’s first cold supply chain company with a nationwide network. Gateway Distriparks Limited is their promoter and largest shareholder.

With over 25 years of experience in temperature-controlled warehousing and transportation, Snowman has been able to gather some big clients. These clients are from various businesses like pharmaceuticals, QSR (Quick Service Restaurants), meat, seafood, dairy, retail, etc. Few of the client companies to name are ITC, Lupin, Walmart, Pepsi, Pizza Hut, Mother Dairy, Mondelez, Bharat Biotech (potential vaccine manufacturer) and more. Snowman offers a variety of services from consultancy to transportation to distribution. 

The chart below will explain their end-to-end solutions in a detailed manner.

[Source: Snowman’s corporate presentation]

The products which Snowman deals with are temperature-controlled. Due to this, it becomes very important to take special care of them. To get real-time updates, Snowman has incorporated an ERP system. This ERP system is a technology with which they trace all their trucks and warehouses. This real-time monitoring helps them to optimize and secure their operations. Currently, they hold pallet capacity of 105,228 in 31 warehoused across 15 cities. These 15 cities include Kochi, Chennai, Banglore, Mumbai, Delhi, Ahmedabad, etc. You can find Snowman’s 2019-20 annual report here.

Pfizer & Snowman

US-based Pfizer Inc and Germany-based BioNTech developed a vaccine which proved to be 95% effective in preventing Covid-19. The UK government became the first country on 2nd December to approve the use of Pfizer-BioNTech’s covid-19 vaccine. Reports suggest that this vaccine will be available across the UK from next week. The US Food and Drug Administration (FDA) will meet on 10th December to discuss whether to authorize the COVID-19 vaccine developed by Pfizer Inc.

Can it come to India? There are many roadblocks of this vaccine coming to India. The biggest is the temperature it has to be stored and transported. According to reports, Pfizer’s vaccine requires an ultra-cold chain of -70 degrees. India does not have many logistics companies which can provide logistics services at such low temperature. Snowman Logistics is one of the very few Indian companies which can offer services similar to what is required by Pfizer’s vaccine.

According to Snowman’s CEO Sunil Nair, their current facilities can provide logistics and storage up to -40 degrees. But if it requires more than that, any company in the world will find it hard to offer their services if the technology is not improved. He added “Going up to -40 degree Celcius if I take that as then we have one lakh pellets positions total capacity and as of now the spare capacity is around 15,000 pellets positions and depending on the requirement we can increase it by creating some more space. Each pellet can accommodate 6000-7000 doses of vaccine.” 

The sudden rise in Snowman’s share price 1-Day candle

The day Pfizer’s vaccine news came out, Snowman Logistics’ share went 8% up. The chart below depicts how the investors have got behind this stock. In March, the stock touched its 52-week low at Rs 24.60. Since then, it has really struggled to get back up. Till 3rd November, the stock was trading in the early 30s. In just one month, it went from Rs 34 to Rs 67.30. Almost a double! That’s why it is often said that the stock market is unpredictable. But believe us, if you know the fundamental reason behind the happenings, you will always be a better and a knowledgeable investor in the long-run.

Financial Performance of Snowman Logistics

The company may have an amazing business opportunity, but how strong are they fundamentally? Let’s check out.

March 2020March 2019March 2018
Net Sales240.20232.55194.28
EBITDA60.1946.7944.46
PBT-6.3110.86-3.56
Values in Rs Crore

Snowman Logistics registered a mere 3% YoY rise in total revenue in FY20. But at the same time, they failed to record a profit for the third time in the last four years. Between 2017 to 2020, they recorded a profit only once and it was in 2019. This is mostly because of the high depreciation. In FY20, the company calculated total depreciation to be more than Rs 50 crore. That means, more than one-fifth of their total revenue was lost in covering for depreciation.

On a positive side, Snowman Logistics reported a positive net cash flow for the first time in the last five years. The company reported a net cash inflow of Rs 1.13 crore. Apart from depreciation, a major chunk of Snowman’s money goes out to pay the debt. They have maintained a very low debt-toequity ratio which means most of the money has come through equity rather than debt. Snowman’s current debt-to-equity ratio is 0.15. This ratio was 0.32 in 2018. Overall, the company has not performed well financially over the past 5 years. Yet, the continuous decreasing debt pattern provides a brighter look to the company. Any company which has less debt, with a good market to compete in, is considered less risky by the investors. You can also look into its peer cold supply chain companies like Blue Star.

In another note, Adani Logistics offloaded approximately 9.59 lakh equity shares indicating 0.57% stake in the company at Rs 55.64 per share last day. This is not looking like a good sign.

Be it vaccines or FMCG products, cold-chain supply in India is set to witness a boom. Can Snowman Logistics take advantage of this? Or will the stock fall after the recent rally based on potential vaccine news be futile? Let us wait and watch.

Categories
Trending

Moderna Vaccine Submitted for Approval

Moderna submitted its 95% success rate vaccine for approval from USFDA(United States Food and Drug Administration). The company said that they have enough information on the trials conducted, and they are proceeding with their application. The clinical trials from more than 30,000 volunteers showed the vaccine prevented virtually all symptomatic cases of Covid-19.

Moderna expects that on December 17, the FDA will be ready for a public meeting to discuss this data. They will also seek approval from the European Medicines Agency. Moderna shares price went up by 20% in the US as a reaction to the news. The vaccines may be available for commercial use this month and the supply will also be limited.

To know more about the stocks that could benefit from Covid-19 vaccines, click here.

Moderna received more than $1 billion in U.S federal government funding to develop and produce its vaccine. They have also received $1.5 billion to supply it to the American public as soon as it is available in the market. India is also likely to get Moderna’s vaccine through the COVAX facility, which is a global initiative to bring together governments and manufacturers to ensure and accelerate the development and manufacturing of Covid-19 vaccines. India hasn’t signed any advance purchase agreement for Moderna’s vaccine.

For more details about the approval of Moderna’s vaccine visit here.

Categories
Market News Top 10 News

DBS Completes Takeover of Lakshmi Vilas Bank – Top Indian Market News

DBS completes takeover of Lakshmi Vilas Bank

Singapore-based DBS Group, on Monday, stated that its Indian subsidiary- DBS Bank India- has completed the takeover of distressed Lakshmi Vilas Bank (LVB). LVB’s banking services have been restored, with all branches, digital channels, and ATMs functioning as usual. The interest rates on savings bank accounts and fixed deposits will remain unchanged until further notice. All employees of LVB will continue in service and are now part of DBS Bank’s workforce. 

Read more here.

Govt likely to spend Rs 18,000 crore on priority vaccination for Covid-19

The Indian Government is likely to spend Rs 18,000 crore for the first phase of priority vaccination for Covid-19. This is according to a report from CNBC-TV18. The projected cost has been estimated by an expert panel comprising of Niti Ayog and Health Ministry officials. Currently, the panel is in the process of identifying 30 crore priority beneficiaries such as health care workers, police, sanitation workers, and the elderly. However, the report also states that these are approximations and the actual cost is yet to be finalised.

Read more here.

Banks in India to see capital decline over two years without fresh infusion: Moody’s

A report from Moody’s Investors Service stated that Indian banks will see a larger capital decline without further infusion, over the next two years. Moody’s says that the uncertain trajectory of asset quality is one of the biggest threats for emerging market banks. The report also states that the 2021 outlook for banks in emerging markets (such as India) is negative.

Read more here.

Hindustan Construction, Vensar JV wins Rs 236 crore railway order

Hindustan Construction Company Ltd, in a joint venture with Vensar Constructions Company Ltd, has bagged two contracts worth Rs 236 crore, from the Northeast Frontier Railway. The companies will construct a portion of the Bairabi-Sairang broad gauge rail line. This is part of the Indian Railways’ plans to improve its network across North-East India. Hindustan Construction’s share in the order is placed at Rs 130 crore.

Read more here.

Shapoorji’s $1.2 billion deal with ADIA on hold over debt issues: Report

The Shapoorji Pallonji Group has kept its logistics venture with Abu Dhabi Investment Authority (ADIA) on hold. According to a report from Business Standard, the reason for keeping the deal on hold is due to debt issues and the ongoing Covid-19 pandemic. The group had planned to launch a $1.2 billion (~Rs 8,874 crore) venture with ADIA to invest in logistic centres in India.

Read more here.

Serum Institute rejects volunteer’s claims of suffering side effects; seeks damages worth Rs 100 crore

The Serum Institute of India (SII) filed a Rs 100 crore defamation case against a Chennai-based volunteer who took part in its ‘Covidshield’ vaccine trials. The volunteer had alleged that the vaccine triggered an adverse reaction, which included neurological impairment. On November 21, the volunteer sent a legal notice and sued SII for Rs 5 crore. SII has denied the allegations and has stated that there was no correlation between the vaccine trial and the medical condition of the volunteer.

Read more here.

Tata Sons may raise stake to over 76% in AirAsia India by end of FY21: Report

As per a report from Business Standard, Tata Sons is planning to gradually raise its stake in AirAsia India to more than 76% by the end of 2020-21. This may allow Malaysia-based AirAsia Group (which holds a 49% stake in the company) to exit its operations from India. The AirAsia Group earlier stated that it was struggling to recover from the Covid-19 impact, and had hinted at exiting its operations in India.

Read more here.

Paytm Money launches IPO investments for retail investors

Paytm’s wholly-owned subsidiary, Paytm Money, will now facilitate investments in Initial Public Offerings (IPOs). It will enable investors to instantly apply for the latest IPOs from their UPI-linked bank accounts and complete the application process in 3-4 days. The company is aiming to capture 8-10% of applications market share in the first year of launch.

Read more here.

IHCL announces expansion in eastern India with Ambuja Neotia Group

Indian Hotels Company Ltd (IHCL) has announced the signing of three hotels in eastern India (two in Kolkata and one in Patna), with the Ambuja Neotia Group. The company’s CEO Puneet Chhatwal stated that 60% of revenue in FY21 is expected to come from its leisure segment. He further stated that IHCL will be present in 9 out of 10 states in the east. IHCL, which runs the Taj group of luxury hotels, is owned by the Tata Group.

Read more here.

Indian Railways record 371% increase in electrification during 2014-2020

Piyush Goyal, the Union Minister of Railways, stated that the electrification of 18,065 km of railway lines has been completed during 2014-2020. There constitutes a 371% increase in electrification, as compared to the period between 2009-2014. The minister also stated that the electrification process will help eliminate pollution, cut down imports of fuel, and save costs.

Read more here.